Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Clesrovimab
Related studies linked through entity extraction aliases.
Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase 2a Respiratory Syncytial Virus (RSV) Human Challenge Study of Clesrovimab (MK-1654) in Healthy Participants (MK-1654-005)
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2